Last update 19 Jun 2025

Cytokine-induced killer cell(Chinese PLA General Hospital)

Overview

Basic Info

Drug Type
CIK therapy
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
B-Cell LymphomaSolid tumor
Originator Organization
Chinese People's Liberation Army General HospitalChinese People's Liberation Army General Hospital
Active Organization-
Inactive Organization
Chinese People's Liberation Army General HospitalChinese People's Liberation Army General Hospital
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with Cytokine-induced killer cell(Chinese PLA General Hospital)
NCT01799083
/ Unknown statusPhase 1/2
Phase 1/2 Study of Decitabine Alone and/or in Combination With Chemotherapy and/or Cytokine Induced Killer Cell Transfusion in Patients With Relapsed or Refractory Solid Tumors and B Cell Lymphomas
100 Clinical Results associated with Cytokine-induced killer cell(Chinese PLA General Hospital)
Login to view more data
100 Translational Medicine associated with Cytokine-induced killer cell(Chinese PLA General Hospital)
Login to view more data
100 Patents (Medical) associated with Cytokine-induced killer cell(Chinese PLA General Hospital)
Login to view more data
100 Deals associated with Cytokine-induced killer cell(Chinese PLA General Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-Cell LymphomaPhase 2
China
Chinese People's Liberation Army General HospitalChinese People's Liberation Army General Hospital
01 Dec 2012
Solid tumorPhase 2
China
Chinese People's Liberation Army General HospitalChinese People's Liberation Army General Hospital
01 Dec 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free